Literature DB >> 3710271

Cyclophosphamide, adriamycin, and cis-platinum for the treatment of advanced granulosa cell tumor, using serum estradiol as a tumor marker.

S B Kaye, E Davies.   

Abstract

Two cases of advanced granulosa cell tumor are described, in both of which chemotherapy comprising cyclophosphamide, adriamycin, and cis-platinum resulted in an objective partial response with marked symptomatic improvement. In one case the response continues at 12 months, in the other the response lasted for 5 months. In both cases elevated serum estradiol levels fell during treatment. A literature review reveals two previous cases in which this combination has been reported as being effective in advanced granulosa cell tumor, but this is the first report of the use of serum estradiol as a tumor marker.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3710271     DOI: 10.1016/0090-8258(86)90035-1

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

Review 1.  Minireview: roles of the forkhead transcription factor FOXL2 in granulosa cell biology and pathology.

Authors:  Margareta D Pisarska; Gillian Barlow; Fang-Ting Kuo
Journal:  Endocrinology       Date:  2011-01-19       Impact factor: 4.736

Review 2.  Adult-type granulosa cell tumor of the ovary.

Authors:  Xiuwen Li; Bo Tian; Mengyan Liu; Chunlei Miao; Di Wang
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

3.  A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group Study.

Authors:  Elizabeth R Burton; Mark Brady; Howard D Homesley; Peter G Rose; Toshiaki Nakamura; Joshua P Kesterson; Jacob Rotmensch; J Tate Thigpen; Linda Van Le
Journal:  Gynecol Oncol       Date:  2015-11-23       Impact factor: 5.482

4.  Endogenous c-Jun N-terminal kinase (JNK) activity marks the boundary between normal and malignant granulosa cells.

Authors:  Gamze Bildik; Nazli Akin; Filiz Senbabaoglu; Yashar Esmalian; Gizem Nur Sahin; Defne Urman; Sercin Karahuseyinoglu; Umit Ince; Erhan Palaoglu; Cagatay Taskiran; Macit Arvas; Yilmaz Guzel; Kayhan Yakin; Ozgur Oktem
Journal:  Cell Death Dis       Date:  2018-04-01       Impact factor: 8.469

5.  Constitutively active transforming growth factor β receptor 1 in the mouse ovary promotes tumorigenesis.

Authors:  Yang Gao; David F Vincent; Anna Jane Davis; Owen J Sansom; Laurent Bartholin; Qinglei Li
Journal:  Oncotarget       Date:  2016-07-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.